The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.

Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C, Scatena R, Pontoglio A, Castellini L, Spelbrink JN, Maulucci G, Puglisi MA, Pani G, Gasbarrini A
Sci Rep. 2015 Mar 17;5:9149. doi: 10.1038/srep09149. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.